Lista de obras -

A Blood-Based Multi Marker Assay Supports the Differential Diagnosis of Early-Stage Pancreatic Cancer

A randomised phase II study of irinotecan in combination with 5-FU/FA compared with irinotecan alone as second-line treatment of patients with metastatic colorectal carcinoma.

artículo científico publicado en 2007

Adjuvant therapy in colon cancer

artículo científico publicado en 2010

Adjuvant therapy of colon carcinoma

artículo científico publicado en 2008

Amphiphysin-positive paraneoplastic myelitis and stiff-person syndrome

artículo científico publicado en 2016

Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients-Analysis of the Phase III AIO KRK-0207 Trial

article

Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing

artículo científico publicado en 2016

Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience

artículo científico publicado en 2017

Cetuximab-based or bevacizumab-based first-line treatment in patients with KRAS p.G13D-mutated metastatic colorectal cancer: a pooled analysis

artículo científico publicado en 2012

Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma

artículo científico publicado en 2012

Colorectal Adenoma - Resection Techniques and Surveillance

artículo científico publicado en 2014

Colorectal carcinoma: the management of polyps, (neo)adjuvant therapy, and the treatment of metastases

artículo científico publicado en 2009

Colorectal liver metastases. Neoadjuvant chemotherapy: aspects of medical and surgical oncology

artículo científico publicado en 2007

Docetaxel, oxaliplatin and capecitabine (TEX regimen) in patients with metastatic gastric or gastro-esophageal cancer: results of a multicenter phase I/II study.

artículo científico publicado en 2013

Drug insight: antiangiogenic therapies for gastrointestinal cancers--focus on monoclonal antibodies

artículo científico publicado en 2008

Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study group

artículo científico publicado en 2012

FOLFIRINOX treatment leading to pathologic complete response of a locally advanced pancreatic cancer.

artículo científico publicado en 2018

Feasibility and diagnostic utility of video capsule endoscopy for the detection of small bowel polyps in patients with hereditary polyposis syndromes.

artículo científico publicado en 2005

Gefitinib in combination with capecitabine as second-line therapy in patients with advanced colorectal cancer (aCRC): a phase I/II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

artículo científico publicado en 2010

Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system ⬇️

artículo científico publicado el 3 de enero de 2011

Immunoscreening of the extracellular proteome of colorectal cancer cells

artículo científico publicado en 2010

Label-free imaging of drug distribution and metabolism in colon cancer cells by Raman microscopy

artículo científico publicado en 2014

Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas

artículo científico publicado en 2004

Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial

artículo científico publicado en 2015

MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL.

artículo científico publicado en 2012

Multiple cerebral infarctions in a young patient with heroin-induced hypereosinophilic syndrome.

artículo científico publicado en 2015

Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group

article published in 2018

Peri-operative chemotherapy for the treatment of resectable liver metastases from colorectal cancer: A systematic review and meta-analysis of randomized trials

artículo científico publicado en 2010

Prevention of colorectal cancer in inflammatory bowel disease: value of screening and 5-aminosalicylates

artículo científico publicado en 2006

Prognostic Value of Reduced SMAD4 Expression in Patients With Metastatic Colorectal Cancer Under Oxaliplatin-Containing Chemotherapy: A Translational Study of the AIO Colorectal Study Group ⬇️

artículo científico publicado el 1 de marzo de 2011

SMAD4 mediates mesenchymal-epithelial reversion in SW480 colon carcinoma cells

artículo científico publicado el 1 de julio de 2010

Severe refractory CIDP: a case series of 10 patients treated with bortezomib.

artículo científico publicado en 2017

Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells

artículo científico publicado en 2002

TFAP2E-DKK4 and chemoresistance in colorectal cancer

artículo científico publicado en 2012

The influence of 5-aminosalicylic acid on the progression of colorectal adenomas via the ss-catenin signaling pathway ⬇️

artículo científico publicado el 22 de diciembre de 2011

Truncating mutations in Peutz-Jeghers syndrome are associated with more polyps, surgical interventions and cancers

artículo científico publicado en 2009

What does physicians' clinical expertise contribute to oncologic decision-making? A qualitative interview study.

artículo científico publicado en 2017

[ASCO- and ESMO-update 2017 - highlights of the 53. meeting of the American Society of Clinical Oncology/ASCO 2017 and European Society for Medical Oncology/ESMO congress 2017].

artículo científico publicado en 2018

[Colorectal carcinoma--molecular markers in clinical routine]

artículo científico publicado en 2008

[Controversies in gastrointestinal oncology]

artículo científico publicado en 2008

[Gastrointestinal tumors--interdisciplinary discussion over new data].

artículo científico publicado en 2011

[Physician perspectives on the impact of patient preferences and the role of next-of-kin of patients in evidence-based decision-making: A qualitative interview study from oncology].

artículo científico publicado en 2018

[Surgical and perioperative therapy of liver metastases]

scientific article published on 14 November 2008

[Treatment of nonresectable liver metastases]

artículo científico publicado en 2008

ß-Catenin, Cox-2 and p53 immunostaining in colorectal adenomas to predict recurrence after endoscopic polypectomy

artículo científico publicado en 2013

Lista de obras de

A Blood-Based Multi Marker Assay Supports the Differential Diagnosis of Early-Stage Pancreatic Cancer

A randomised phase II study of irinotecan in combination with 5-FU/FA compared with irinotecan alone as second-line treatment of patients with metastatic colorectal carcinoma.

Adjuvant therapy in colon cancer

Adjuvant therapy of colon carcinoma

Amphiphysin-positive paraneoplastic myelitis and stiff-person syndrome

Amphiregulin (AREG) and Epiregulin (EREG) Gene Expression as Predictor for Overall Survival (OS) in Oxaliplatin/Fluoropyrimidine Plus Bevacizumab Treated mCRC Patients-Analysis of the Phase III AIO KRK-0207 Trial

Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing

Bortezomib in severe MuSK-antibody positive myasthenia gravis: first clinical experience

Cetuximab-based or bevacizumab-based first-line treatment in patients with KRAS p.G13D-mutated metastatic colorectal cancer: a pooled analysis

Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma

Colorectal Adenoma - Resection Techniques and Surveillance

Colorectal carcinoma: the management of polyps, (neo)adjuvant therapy, and the treatment of metastases

Colorectal liver metastases. Neoadjuvant chemotherapy: aspects of medical and surgical oncology

Docetaxel, oxaliplatin and capecitabine (TEX regimen) in patients with metastatic gastric or gastro-esophageal cancer: results of a multicenter phase I/II study.

Drug insight: antiangiogenic therapies for gastrointestinal cancers--focus on monoclonal antibodies

Effect of KRAS codon13 mutations in patients with advanced colorectal cancer (advanced CRC) under oxaliplatin containing chemotherapy. Results from a translational study of the AIO colorectal study group

FOLFIRINOX treatment leading to pathologic complete response of a locally advanced pancreatic cancer.

Feasibility and diagnostic utility of video capsule endoscopy for the detection of small bowel polyps in patients with hereditary polyposis syndromes.

Gefitinib in combination with capecitabine as second-line therapy in patients with advanced colorectal cancer (aCRC): a phase I/II study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system ⬇️

Immunoscreening of the extracellular proteome of colorectal cancer cells

Label-free imaging of drug distribution and metabolism in colon cancer cells by Raman microscopy

Loss of Smad4 correlates with loss of the invasion suppressor E-cadherin in advanced colorectal carcinomas

Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial

MiR-30a-5p suppresses tumor growth in colon carcinoma by targeting DTL.

Multiple cerebral infarctions in a young patient with heroin-induced hypereosinophilic syndrome.

Neoadjuvant plus adjuvant or only adjuvant nab-paclitaxel plus gemcitabine for resectable pancreatic cancer - the NEONAX trial (AIO-PAK-0313), a prospective, randomized, controlled, phase II study of the AIO pancreatic cancer group

Peri-operative chemotherapy for the treatment of resectable liver metastases from colorectal cancer: A systematic review and meta-analysis of randomized trials

Prevention of colorectal cancer in inflammatory bowel disease: value of screening and 5-aminosalicylates

Prognostic Value of Reduced SMAD4 Expression in Patients With Metastatic Colorectal Cancer Under Oxaliplatin-Containing Chemotherapy: A Translational Study of the AIO Colorectal Study Group ⬇️

SMAD4 mediates mesenchymal-epithelial reversion in SW480 colon carcinoma cells

Severe refractory CIDP: a case series of 10 patients treated with bortezomib.

Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells

TFAP2E-DKK4 and chemoresistance in colorectal cancer

The influence of 5-aminosalicylic acid on the progression of colorectal adenomas via the ss-catenin signaling pathway ⬇️

Truncating mutations in Peutz-Jeghers syndrome are associated with more polyps, surgical interventions and cancers

What does physicians' clinical expertise contribute to oncologic decision-making? A qualitative interview study.

[ASCO- and ESMO-update 2017 - highlights of the 53. meeting of the American Society of Clinical Oncology/ASCO 2017 and European Society for Medical Oncology/ESMO congress 2017].

[Colorectal carcinoma--molecular markers in clinical routine]

[Controversies in gastrointestinal oncology]

[Gastrointestinal tumors--interdisciplinary discussion over new data].

[Physician perspectives on the impact of patient preferences and the role of next-of-kin of patients in evidence-based decision-making: A qualitative interview study from oncology].

[Surgical and perioperative therapy of liver metastases]

[Treatment of nonresectable liver metastases]

ß-Catenin, Cox-2 and p53 immunostaining in colorectal adenomas to predict recurrence after endoscopic polypectomy